USPTO serial 79371355
III DRIEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 14, 2025
- Examiner
- MAJCHER HARTNETT, MEGAN K
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with III DRIEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Zachary A. Aria
Zachary A. Aria Blank Rome LLPOne Logan Square8th FloorPhiladelphia, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Flasks for parenteral nutrition namely, container and drug reconstitution system for injections, infusions and orals, all being medical apparatus in the nature of infusion and injection devices for administering drugs; dropper bottles for medical purposes, in particular for bottles for administering medication, sold empty; vaporizers for medical purposes; suction bottles for medical use, namely feeding bottles, nursing bottles, and dropper bottles for administering medication, sold empty; dropper bottles for administering medication, sold empty; syringes for medical purposes; syringes for injections; haemoperfusion cartridges being structural part of dialysis machines and blood containers for medical purposes; feeding bottles; droppers for medical purposes in particular for administering medication, sold empty; droppers for administering medication, sold empty; trays for holding surgical instruments; measuring spoons for administering medicine; spoons for administering medicine; non-spill medicine administering spoons for infants; intravenous feeding bottles; breast milk storage bottles; medical tubing for administering drugs; injection device for pharmaceuticals; dropping pipettes for medical purposes; diagnostic devices namely, sample preparation device for medical diagnostic use, blood pressure and diabetic diagnostic medical devices, and diagnostic kit consisting primarily of probes, buffers and reagents for use in microbial testing used in laboratories for Point of Care Testing (POCT) for integrated electronic systems for the administration of medical substances; consumable laboratory cartridges for diagnostic purposes, namely, replacement and structural components of medical diagnostic apparatus for detecting diseases, integrated electronic system for the administration of medical substances being drug delivery systems and medical instruments for measuring and displaying blood pressure and lung capacity; medical devices, namely valves and accessories being tubing for intravenous drug administration; apparatus sold as a unit in kit form for medical diagnostic purposes, namely diagnostic kits for clinical medical use primarily containing sample preparation devices for medical diagnostics and also containing test tubes, test plates and indicator charts for evaluating test results; test kits for clinical medical use consisting primarily of sample preparation devices for medical diagnostics and also containing a holder for medical sample tubes and vials also including test tubes, test plates and indicator charts for evaluating test results; containers for medical reagents, namely, containers specially designed for transporting and holding radiopharmaceuticals; systems comprising medical apparatus and accessories for administering measured doses of medical substances, namely medical apparatus and accessories being dosage dispensers for administering medicine to patients, infusion and injections devices for administering drugs; medical instruments for recording physiological data for medical and pharmaceutical purposes in particular for measuring blood pressure; medical prostheses being bone, hip and breast prostheses and implants for surgical purposes comprising artificial materials; sterile containers to be filled with medical products, namely, containers for medical waste, blood containers for medical purposes sold empty; sterile containers for surgical purposes namely, containers for medical waste, blood containers for medical purposes sold empty; empty medical diagnostic cartridges of plastic for containing and administering medical products, namely blood cartridge containers for medical use sold empty; empty medical diagnostic cartridges of glass for containing and administering medical products, namely blood cartridge containers for medical use sold empty; empty medical diagnostic cartridges of plastic for containing and administering reagents namely capillary reagent tubes for medical use; empty medical diagnostic cartridges of glass for containing and administering reagents, namely capillary reagent tubes for medical use; medical needles of metal for parenteral administration; auxiliary medical devices for drug reconstitution, namely tubing for intravenous drug administration; cartridges of plastic for medical diagnostic purposes, namely blood cartridge contains for medical use sold empty; containers made of glass or plastic for pharmaceutical or parapharmaceutical or medical use, namely dropper bottles for administering injectable medication substances sold empty, medical syringes and empty medical diagnostic cartridges being blood cartridge contains for medical use sold empty | ACTIVE | — |
| 020 | Container closures of plastic; plastic medication containers for commercial use; containers, not of metal for commercial use; bottle closures, not of metal; closures for containers, non-metallic; corks for bottles; plastic stoppers for bottles; plastic screw caps and caps of plastic for the closure of containers; sealing caps, not of metal; closures of plastics for containers for detecting tampering | ACTIVE | — |
| 021 | Cruets; cruet stands; contains for household use, namely glass bulbs; flasks; flasks of plastic; empty spray bottles; glass cartridges for medication, empty; pill boxes for personal use; personal dispensers for pills or capsules for domestic use, namely pill boxes for personal use; droppers for cosmetic purposes; glasses, namely drinking glasses; bottles sold empty; containers being glass flasks; plastic bottles sold empty; drip preventers for bottles in the nature of bottle pourers; glass stoppers for bottles; bottles for pharmaceuticals sold empty; apothecary jars, namely glass jars; dispensers for liquids for use with bottles, namely pouring spouts for household use all for use with bottles; containers made of glass or plastic for pharmaceutical or parapharmaceutical or medical use, namely bottles for medicines, bottles for reagents, bottles for infusions, bottles for aerosols, glass vials for medication, glass ampoules for medication, pill bottles, all sold empty; medicinal bottle stoppers of glass | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BORMIOLI PHARMA S.p.A.
- Other trademarks owned by BORMIOLI PHARMA S.p.A.
- Other trademarks owned by BORMIOLI PHARMA S.p.A.
- Other trademarks in Class 010
- Other trademarks in Class 020
- Other trademarks in Class 021
- Similar marks named III DRIEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 23, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 23, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 14, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 14, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 14, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 23, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 6, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 6, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 17, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 17, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 14, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 4, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 4, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 4, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 31, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 31, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 31, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 31, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 31, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 31, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 31, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 29, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 4, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 3, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 13, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 13, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 9, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 8, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |